The Office of Diversion Control, operating under the Drug Enforcement Administration within the Department of Justice, is tasked with safeguarding the integrity of controlled substance supply chains and preventing the illicit diversion of pharmaceuticals and precursor chemicals. Its core mission centers on enforcing federal regulations governing lawful drug manufacturing, distribution, and dispensing, with strategic priorities focused on forensic analysis of emerging psychoactive substances, financial investigations into illicit trafficking networks, and the modernization of digital systems supporting regulatory compliance and intelligence gathering.
Office Of Diversion Control is a government agency with procurement activity across contracts, awards, and contractors. Over the last 12 months, Office Of Diversion Control has obligated $18,554,533, issued 1 award, and worked with 1 contractor.
Spending trends, top contractors, industry breakdown, and recent contract activity.
AI Mission Profile
The Office of Diversion Control, operating under the Drug Enforcement Administration within the Department of Justice, is tasked with safeguarding the integrity of controlled substance supply chains and preventing the illicit diversion of pharmaceuticals and precursor chemicals. Its core mission cen...
The Office of Diversion Control, operating under the Drug Enforcement Administration within the Department of Justice, is tasked with safeguarding the integrity of controlled substance supply chains and preventing the illicit diversion of pharmaceuticals and precursor chemicals. Its core mission centers on enforcing federal regulations governing lawful drug manufacturing, distribution, and dispensing, with strategic priorities focused on forensic analysis of emerging psychoactive substances, financial investigations into illicit trafficking networks, and the modernization of digital systems supporting regulatory compliance and intelligence gathering. Key initiatives include evaluating the abuse potential of novel synthetic compounds, enhancing financial tracking capabilities for enforcement actions, and maintaining robust IT infrastructure to support real-time monitoring of regulated entities.
The agency procures specialized scientific, financial, and information technology services to sustain its regulatory and investigative functions. Contracts are typically structured as performance-based solicitations requiring technical expertise in pharmacological evaluation, forensic accounting, and secure systems design. Recent opportunities reflect a reliance on external service providers for complex, non-routine tasks that require niche domain knowledge beyond internal capacity.
Primary procurement targets include testing laboratories for pharmacological studies, computer systems design services for regulatory platforms, and accounting support for financial investigations. The agency demonstrates a clear preference for vendors with demonstrated capability in controlled substance analytics and financial forensics. While most procurements are open competition, it has utilized SBA small business set-asides, indicating a commitment to fostering partnerships with qualified small firms capable of delivering specialized support services.
Organized as a division within the Drug Enforcement Administration, the Office of Diversion Control operates nationwide without a centralized physical headquarters, relying on decentralized field offices and federal partnerships. It utilizes standard federal contracting vehicles including indefinite-delivery/indefinite-quantity (IDIQ) contracts and performance-based service agreements to acquire mission-critical technical and analytical services.
Procurement Analytics
Where Office Of Diversion Control directs its contract spending, by industry and small-business set-aside program.
